5 Geographic Atrophy Clinical Trials in Detroit, MI (2026)

Q: How do I join a clinical trial in Detroit?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Detroit research site will contact you.

Recruiting Geographic Atrophy Studies in Detroit

NCT05066217Recruiting

An Efficacy and Safety Study of Clemizole HCl in Patients With Lennox-Gastaut Syndrome

This is a multicenter, Phase 3, randomized, double-blind, placebo-controlled study designed to evaluate the efficacy and safety of clemizole HCL (EPX-100) as adjunctive therapy in children and adult p...

Detroit, MI260 participantsEpygenix

View Study Details

NCT06709521Recruiting

Optimization of Beta-lactam Dosing in Critically Ill Patients With Cystatin C (OPTIMIZE-GNI)

The purpose of this study is to evaluate the abilities of Cystatin C (CysC) and CysC-based estimated Glomerular Filtration Rate (eGFR) equations to characterize the pharmacokinetics (PK) profiles of m...

Detroit, MI200 participantsNational Institute of Allergy and Infectious Diseases (NIAID)

View Study Details

NCT07021066Recruiting

Evaluate the Safety, Tolerability, Pharmacokinetics and Efficacy of BL-M05D1 in Subjects With Solid Tumors

The objective of this study is to evaluate the Safety, Tolerability, Pharmacokinetics and Efficacy of BL-M05D1 in Subjects with Advanced or Metastatic Solid Tumors....

Detroit, MI160 participantsSystImmune Inc.

View Study Details

NCT06560307Recruiting

Study of Enhanced Programming Stimulation with the Enterra® Therapy System

The purpose of this research study is to evaluate if an enhanced Enterra device programming strategy will improve symptoms associated with gastroparesis, improve symptoms in a faster amount of time, a...

Detroit, MI50 participantsEnterra Medical, Inc.

View Study Details

NCT06065371Recruiting

Sacituzumab Govitecan in Combination With Capecitabine for Advanced Gastrointestinal Cancers After Progression on Standard Therapy

This is a Phase I study to evaluate the safety and tolerability of sacituzumab govitecan in combination with capecitabine for advanced gastrointestinal cancers after progression on standard therapy, a...

Detroit, MI20 participantsHenry Ford Health System

View Study Details

About Geographic Atrophy Clinical Trials in Detroit

Geographic atrophy is the advanced form of dry age-related macular degeneration, involving progressive loss of retinal cells. It leads to enlarging blind spots in central vision. Recently approved complement inhibitor therapies can slow progression.

There are currently 5 geographic atrophy clinical trials recruiting participants in Detroit, MI. These studies are seeking a combined 690 participants. Research is being sponsored by Epygenix, National Institute of Allergy and Infectious Diseases (NIAID), SystImmune Inc. and 2 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Geographic Atrophy Clinical Trials in Detroit — FAQ

Are there geographic atrophy clinical trials in Detroit?

Yes, there are 5 geographic atrophy clinical trials currently recruiting in Detroit, MI. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Detroit?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Detroit research site will contact you about next steps.

Are clinical trials in Detroit free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Detroit studies also compensate for your time and travel.

What geographic atrophy treatments are being tested?

The 5 active trials in Detroit are testing new therapies including novel drugs, biologics, and treatment approaches for geographic atrophy.

Data updated July 13, 2026 from ClinicalTrials.gov